Related Experiment Video
Updated: Jan 15, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53: An Immune Ecosystem Manipulator
Zhigang Nian1,2,3, Yingchao Dou2,3, Haiming Wei1,2,3
1Division of Life Sciences and Medicine, Department of Geriatrics, First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.
None:
Mutations in p53 are among the most common genetic abnormalities in cancer, and the loss of its normal function is a critical factor in cancer progression. In addition to autonomously inhibiting tumorigenesis, p53 mutations reshape the tumor immune microenvironment through various mechanisms. Thus, p53 acts as a critical mediator of immunotherapy resistance. This review elucidates how p53 mutations establish an "immune barrier network" by modulating secretomes (including cytokines and extracellular vesicles), immune ligands, antigen presentation, tumor metabolic reprogramming, and the extracellular matrix. Future research should focus on the specificity of mutant subtypes and organs, as well as their "double-edged sword" characteristics, which balance neoantigen generation and immune suppression, while exploring new strategies for combination immunotherapy that target the immune barrier network.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway

